Skip to main content

Advertisement

Table 2 Objective sleep quality at baseline, N = 15.

From: Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease

Sleep Recording Data at Baseline  
TST 4 h 34 min ± 1 h 13 min
Sleep efficiency 66 ± 18 % of sleep period time
EEG arousals 2.6 ± 3.3 / h of sleep
Movement arousals 9.7 ± 7.1 / h of sleep
Latency to S2 sleep 41 ± 41 min
Stage S1 sleep 87 ± 60 min (34 ± 24 %)
Stage S2 sleep 81 ± 48 min (29 ± 15 %)
SWS 73 ± 39 min (26 ± 10 %)
REM sleep 34 ± 31 min (11 ± 10 %)
  1. Percentages indicate proportion of the total sleep time (TST) unless otherwise indicated. Data presented as mean ± SD. REM = rapid eye movements, SWS = slow wave sleep (sleep stages 3 and 4), TST = total sleep time.